Mayo Clinic Laboratory and Pathology Research Roundup: Oct. 2 - Insights
This week’s Research Roundup highlights immune-mediated autonomic neuropathies following allogeneic stem cell transplantation in acute myeloid leukemia.
Systems Engineering Archives - Insights
Skip to Content MayoACCESS MayoLINK...
Thiopurine Management Testing for IBD - Mayo Clinic Laboratories
Thiopurine management is important because it can detect individuals with low thiopurinemethyltransferase (TPMT) activity who are at risk for excessive myelosuppression or severe hematopoietic toxicity when taking thiopurine drugs.
Viral Hepatitis Testing - Mayo Clinic Laboratories
At Mayo Clinic, we utilize an algorithmic approach to testing that takes the guesswork out of test ordering to focus on proper test utilization, saving your institution time and money.
Learn more about how Mayo Clinic Laboratories’ targeted, high-resolution screening panel for stimulant use identifies and confirms the presence of 10 stimulants and phencyclidine (PCP) with a single test.
Testing Archives - Page 5 of 26 - Insights
Skip to Content MayoACCESS MayoLINK...
CNS Demyelinating Disease Testing - Mayo Clinic Laboratories
We offer the only FACS assay for CNS Demyelinating Disease. Our testing ensures the highest senstivity and specificity, providing the most accurate results for patients.
Inflammatory Bowel Disease: IBDP2 - Insights
In this test specific episode of the "Answers From the Lab" podcast, Melissa Snyder, Ph.D., explains how IBDP2, when used after first-line testing has failed, can distinguish between ulcerative colitis and Crohn’s disease.
Rapid response: COVID-19, monkeypox, and whatever comes next - Insights
Mayo Clinic Laboratories' rapid response to public health threats has been honed during outbreaks of viruses like 2009’s H1N1 influenza, Zika, Ebola and, most recently, COVID-19. Before COVID-19, laboratory staff were already experts in...
Testing Archives - Page 8 of 26 - Insights
Skip to Content MayoACCESS MayoLINK...